Health
Gout drug could reduce Covid hospital stays, new research finds – The Guardian
Colchicine also found to reduce need for extra oxygen and has potential to be used in outpatient settings
A cheap drug normally used to treat gout has been found to have the potential to significantly reduce hospital stays among Covid-19 patients and the need for extra oxygen.
The results of new research into colchicine conducted in Brazil come after an international trial published on Wednesday found that it reduced hospitalisations and deaths among Covid-19 patients by more than 20%.
Colchicine, which is used to treat rheumatic diseases, was hailed by researchers as having the potential to be the…
-
Noosa News24 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Business9 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News24 hours agoAll this country music is giving me the honky-tonk blues
-
Business12 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025